XO1 Deal Shows It Only Takes Two People To Run A Successful Biotech; Venture Capitalists Take Note
(Reuters) - How many people does it take to run a successful biotech company? Just two, judging by the sale of XO1, a one-drug British firm snapped up last month by Johnson & Johnson.
Ten years on from pioneering an ultra-lean business model focused on investing in "virtual" companies with a single experimental medicine, XO1's backer Index Ventures is chalking up some notable wins.
Help employers find you! Check out all the jobs and post your resume.
Ten years on from pioneering an ultra-lean business model focused on investing in "virtual" companies with a single experimental medicine, XO1's backer Index Ventures is chalking up some notable wins.
Help employers find you! Check out all the jobs and post your resume.